Archive for January, 2010

Drug metformin, could revolutionize cancer therapies

Study results suggest that current treatments for diabetes may increase the memory T cells, stimulating the immune system and leading to new strategies for anticancer therapies and vaccines.

As reported in the journal Nature in its last decision, a drug commonly used to control diabetes can boost the immune system and increase the effects of vaccines and treatments against cancer. Read the rest of this entry »

Drug reduces risk of relapse in patients with colon cancer

This is the antiangiogenic bevacizumab, which Roche markets under the name “Avastin, which gets reduced by up to 40 percent the risk of relapse in patients with colorectal cancer after first year of treatment, as is clear from the previous Studies presented at the Annual Meeting of the American Society of Clinical Oncology. Read the rest of this entry »

The skin cancer may be inherited

Family history would also be instrumental in the development of skin cancer, according to studies

Several studies have suggested that melanoma and other skin cancers would be hereditary, however it can be difficult to identify the difference between the influence of genes and environment.

According to two new studies, genetics may be implicated in the occurrence of skin cancer. The findings suggest that some of the increased risk of melanoma may be attributed Read the rest of this entry »

Drinking coffee may reduce risk of endometrial cancer

The authors suggest that coffee alter blood sugar, fat cells and estrogen, which plays a key role in the occurrence of endometrial cancer.

Women who drink at least two cups of coffee have less risk of developing endometrial cancer, according to a study that found that drinking coffee especially to protect women who are overweight or obese. Read the rest of this entry »

Inflammatory associated with lower mortality from colon cancer

Women who use nonsteroidal anti-inflammatory drugs (NSAIDs) have a better survival after diagnosis of colon cancer.

During 2007, the United States were diagnosed in about 112,340 cases of colon cancer and 41,420 rectal cancer, which transforms colorectal tumors in the third most common cancer in American men and women. Read the rest of this entry »

Living near volcanic areas would increase risk of thyroid cancer

New study suggests that people living near volcanic areas have a higher risk of developing such disease.

Although thyroid cancer is quite rare, its incidence has increased in recent decades in the U.S., France, Italy and other countries. Between 2002 and 2004, a team of Read the rest of this entry »

A substance in curry combat the cancer of the esophagus

According to a study by researchers at the Cancer Research Center in Cork (Ireland), curry powder, a species that provides a slightly spicy flavor to foods, it would be effective at killing cancer cells.

And other scientific studies had claimed that the curry may help fight tumors and that those who eat lots of this kind, would be less likely to suffer from these diseases. Read the rest of this entry »

Relationship between cholesterol and the risk of prostate cancer

One study, which involved more than 5,000 American men, conducted by the Johns Hopkins Health Facility has shown that low cholesterol levels up to 60% would reduce the risk of prostate cancer more aggressive.

Read the rest of this entry »

Genes that trigger breast cancer risk

Researchers have studied the interaction of four genes identified as likely to trigger the most common tumor and feared by women, breast.

The four identified genes, called FGFR2, TNRC9, MAP3K1 and LSP1 are related to the organic processes of growth and cell signaling, issues which had not been deepened too.
The genetic pathway for the repair of DNA damage has been the most studied so far.
The idea is to decode the genetic profile of susceptibility to breast cancer. Read the rest of this entry »

Arimidex in the treatment of breast cancer

As reported in the British Journal of Cancer (BJC), confirms that Arimidex (anastrozole) is an effective treatment for early breast cancer.
Clearly Arimidex offers a cost-effective alternative to tamoxifen in the adjuvant treatment of postmenopausal women with early breast cancer dependent.
Arimidex continues to be the first and Read the rest of this entry »

Research Tips

Just as you would search for the best oncologist by reading reviews, articles and even items published by an oncologist to make sure you get the best treatment for yourself or a loved one you should also read reviews on hosting providers prior to selecting one. Do your reasearch so you will be better prepared when it comes time to make the final decision.